TORONTO DOMINION BANK
BankPosition in REVB — Revelation Biosciences, Inc.
CIK 947263
TORONTO, ONTARIO, A6
Position in REVB
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$0
+$0 QoQ
Shares Held
99,550
+0.1% QoQ
Ownership
2.50%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in REVB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026TORONTO DOMINION BANK holds $788,636,313 across 52 Biotechnology names. REVB ranks #49 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PTCT |
Ptc Therapeutics, Inc.
|
3,025,963 | $206,158,858 | |
| 2 | STOK |
Stoke Therapeutics, Inc.
|
3,173,258 | $103,321,280 | |
| 3 | CELC |
Celcuity Inc.
|
882,758 | $100,757,998 | |
| 4 | IMTX |
Immatics N.V.
|
7,436,342 | $73,173,605 | |
| 5 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
130,460 | $68,291,895 | |
| 6 | URGN |
UroGen Pharma Ltd.
|
2,616,714 | $47,048,517 | |
| 7 | TARS |
Tarsus Pharmaceuticals, Inc.
|
510,253 | $35,794,247 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
78,472 | $35,040,886 |
All Filings in REVB
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 REVBW | — | 99,550 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 REVBW | — | 99,450 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 REVBW | — | 99,450 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 REVBW | — | 99,600 | Shares | Defined | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||